Fall 2012 – Summer 2013
Revision, May 2012. Start of revision.
The Honours program is designed to offer, in addition to the substantial background given by the Major program, a significant research experience in a laboratory within the Department during the U3 year. Students are prepared for this independent research project by following an advanced laboratory course in U2. This program is intended to prepare students for graduate study in microbiology and immunology or related fields, but could also be chosen by students intending to enter medical research after medical school, or intending to enter the job market in a laboratory research environment.
Students intending to apply to Honours must follow the Major program in U1 and U2 and must obtain a CGPA of at least 3.50 at the end of their U2 year. For graduation in Honours, students must pass all required courses with a C or better, and achieve a sessional GPA of at least 3.30 in the U3 year.
* Students who have taken CHEM 212 in CEGEP are exempt and must replace these credits with an elective course(s).
** Students who have taken CHEM 222 in CEGEP are exempt and must replace these credits with an elective course(s).
|BIOL 200||(3)||Molecular Biology|
|BIOL 202||(3)||Basic Genetics|
|CHEM 212*||(4)||Introductory Organic Chemistry 1|
|CHEM 222**||(4)||Introductory Organic Chemistry 2|
|MIMM 211||(3)||Introductory Microbiology|
|MIMM 212||(2)||Laboratory in Microbiology|
|MIMM 214||(3)||Introductory Immunology: Elements of Immunity|
3 credits selected from:
|ANAT 458||(3)||Membranes and Cellular Signaling|
|BIOC 404||(3)||Biophysical Chemistry|
|BIOC 450||(3)||Protein Structure and Function|
|BIOC 454||(3)||Nucleic Acids|
|BIOC 458||(3)||Membranes and Cellular Signaling|
|BIOL 520||(3)||Gene Activity in Development|
|BIOT 505||(3)||Selected Topics in Biotechnology|
|CHEM 203||(3)||Survey of Physical Chemistry|
|CHEM 204||(3)||Physical Chemistry/Biological Sciences 1|
|MIMM 414||(3)||Advanced Immunology|
|MIMM 509||(3)||Inflammatory Processes|
|PHAR 562||(3)||General Pharmacology 1|
|PHAR 563||(3)||General Pharmacology 2|
Revision, May 2012. End of revision.